Cite
HARVARD Citation
Kobayashi, K. et al. (2021). Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study. Japanese journal of clinical oncology. pp. 544-551. [Online].